News & Press - BioFlorida, Inc.

News & Press

Read about recent events, essential information and the latest community news.

Scientific Advancements
Tuesday, August 25, 2020 (0 Comments - view/add) AGTC Announces Publication of Preclinical Data that Support the Ongoing Clinical Development of Its » AGTC Announces Publication of Preclinical Data that Support the Ongoing Clinical Development of Its XLRP Gene Therapy Prog...
Sunday, August 23, 2020 (0 Comments - view/add) Expanded Access Program for Convalescent Plasma discontinues enrollment as FDA authorizes its emerge » By Colette Gallagher Expanded Access Program for Convalescent Plasma discontinues enrollment...
Wednesday, August 12, 2020 (0 Comments - view/add) Florida chosen for coronavirus vaccine test program run by the CDC » Florida chosen for coronavirus vaccine test program run by the CDC By Christine Sexton News Service of...
Tuesday, August 11, 2020 (0 Comments - view/add) Romark Initiates New Phase 3 Clinical Trial of Nt-300 For The Treatment Of COVID-19 » ROMARK INITIATES NEW PHASE 3 CLINICAL TRIAL OF NT-300 FOR THE TREATMENT OF COVID-19 NT-300 clinical p...
Tuesday, August 11, 2020 (0 Comments - view/add) UCF Researchers Utilize Human-on-a-Chip® Approach to Model ALS Pathology » UCF Researchers Utilize Human-on-a-Chip ® Approach to Model ALS Pathology...
Tuesday, August 11, 2020 (0 Comments - view/add) Catalyst Pharmaceuticals Announces Notice of Allowance of a U.S. Patent Application for "Methods of » Catalyst Pharmaceuticals Announces Notice of Allowance of a U.S. Patent Application for "Methods of Adminis...
Thursday, August 6, 2020 (0 Comments - view/add) FDA Approves Two Emergency INDs for COVID-19 Outpatient Therapy » FDA Approves Two Emergency INDs for COVID-19 Outpatient Therapy First Reported eIND Issued for Outpatient COVID-19...
Thursday, August 6, 2020 (0 Comments - view/add) Catalyst Pharmaceuticals’ Firdapse® (amifampridine phosphate) Receives Marketing Approval in Canada » Catalyst Pharmaceuticals’ Firdapse® (amifampridine phosphate) Receives Marketing Approval in Canada for Patients with LEMS...
Wednesday, July 29, 2020 (0 Comments - view/add) SMH Expands COVID-19 Antibody Cocktail Trial to People Recovering at Home » SMH Expands COVID-19 Antibody Cocktail Trial to People Recovering at Home July 29,...
Tuesday, July 28, 2020 (0 Comments - view/add) Hesperos demonstrates innovative Human-on-a-Chip® approach to modeling innate immune system response » Hesperos demonstrates innovative Human-on-a-Chip® approach to modeling innate immune system response following tissue dama...
Monday, July 27, 2020 (0 Comments - view/add) COVID vaccine study with 30,000 volunteers launched with Vice President Pence touting UM’s role in M » COVID vaccine study with 30,000 volunteers launched with Vice President Pence touting UM’s role in Miami By Cindy K...
Thursday, July 23, 2020 (0 Comments - view/add) Axogen RECON Clinical Study Completes Target Enrollment of 220 Subjects » Axogen RECON Clinical Study Completes Target Enrollment of 220 Subjects RECON is a pivotal study supporting the Co...
Wednesday, July 22, 2020 (0 Comments - view/add) AGTC Announces Updated Development Plan for its X-Linked Retinitis Pigmentosa Clinical Program, Incl » AGTC Announces Updated Development Plan for its X-Linked Retinitis Pigmentosa Clinical Program, Including Q1 2021 Start of...
Wednesday, July 22, 2020 (0 Comments - view/add) AGTC Announces Updated Development Plan for its X-Linked Retinitis Pigmentosa Clinical Program, Incl » AGTC Announces Updated Development Plan for its X-Linked Retinitis Pigmentosa Clinical Program, Including Q1 2021 Star...
Wednesday, July 22, 2020 (0 Comments - view/add) Preclinical Study Shows SARS-CoV-2 Spike Protein Licensed by Oragenics from the NIH Produces Neutral » Preclinical Study Shows SARS-CoV-2 Spike Protein Licensed by Oragenics from the NIH Produces Neutralizing Antibodies...
Monday, July 13, 2020 (0 Comments - view/add) Akron Biotech Submits eCTD Drug Master Files with FDA for Its Suite of cGMP Immunotherapy Cytokines » Akron Biotech Submits eCTD Drug Master Files with FDA for Its Suite of cGMP Immunotherapy Cytokines Leading-Edge...
Wednesday, July 1, 2020 (0 Comments - view/add) Pfizer and BioNTech Announce Early Positive Data from an Ongoing Phase 1/2 study of mRNA-based Vacci » Pfizer and BioNTech Announce Early Positive Data from an Ongoing Phase 1/2 study of mRNA-based Vaccine Candidate Against S...
Tuesday, June 30, 2020 (0 Comments - view/add) GRDG Sciences and Chemia Corp. Announce 3F Biofragrance Success Against COVID-19 » GRDG Sciences and Chemia Corp. Announce 3F Biofragrance Success Against COVID-19 WINTER HAVEN, Fla. , June 30, 2020...
Monday, June 29, 2020 (0 Comments - view/add) Gift of Life Marrow Registry, Root, and Rutgers researchers launch crowd study of tissue match genes » Gift of Life Marrow Registry, Root, and Rutgers researchers launch crowd study of tiss ue match genes in COVID-19...
Monday, June 29, 2020 (0 Comments - view/add) Cytocom, Inc. Announces Successful Completion of Type-B Pre-IND Meeting with FDA Regarding Proposed » Cytocom, Inc. Announces Successful Completion of Type-B Pre-IND Meeting with FDA Regarding Proposed Phase 2 Clinical Trial...
Monday, June 22, 2020 (0 Comments - view/add) 50% Complete Response Rate Observed in YourVaccx™ Study for Patients with Metastatic Prostate Cance » 50% Complete Response Rate Observed in YourVaccx ™ Study for Patients with Metastatic Prostate Cancer was Presented a...
Friday, June 12, 2020 (0 Comments - view/add) Mutated coronavirus shows significant boost in infectivity » Mutated coronavirus shows significant boost in infectivity COVID-19-causing viral variant taking over in the United St...
Wednesday, June 10, 2020 (0 Comments - view/add) Dyadic and Frederick National Laboratory to Develop Cell Lines for COVID-19 Vaccine Candidates Using » Dyadic and Frederick National Laboratory to Develop Cell Lines for COVID-19 Vaccine Candidates Using Dyadic'...
Thursday, June 4, 2020 (0 Comments - view/add) Espero BioPharma, Inc. Expands Collaboration Effort for Tecarfarin » Espero BioPharma, Inc. Expands Collaboration Effort for Tecarfarin JACKSONVILLE, Fla. and IRVINE, Calif. , June 4,...
Wednesday, June 3, 2020 (0 Comments - view/add) Transparency Life Sciences and Lakewood Amedex Launch Protocol Design for New Clinical Trial on Chro » Transparency Life Sciences and Lakewood Amedex Launch Protocol Design for New Clinical Trial on Chronic Diabetic Foot Ulce...
Tuesday, June 2, 2020 (0 Comments - view/add) Relief Therapeutics and NeuroRx Announce Enrollment of First Patients with RLF- 100 in Phase 2b/3 Cl » Relief Therapeutics and NeuroRx Announce Enrollment of First Patients with RLF- 100 in Phase 2b/3 Clinical Trial in Patien...
Tuesday, June 2, 2020 (0 Comments - view/add) Hesperos demonstrates innovative Human-on-a-Chip® approach to modeling innate immune system response » Hesperos demonstrates innovative Human-on-a-Chip® approach to modeling innate immune system response following tissue dama...
Monday, June 1, 2020 (0 Comments - view/add) Longeveron Announces Japanese Approval of Clinical Trial for Treatment of Aging Frailty With Longeve » Longeveron Announces Japanese Approval of Clinical Trial for Treatment of Aging Frailty With Longeveron's Stem Cells Th...
Monday, June 1, 2020 (0 Comments - view/add) FDA Authorizes OPKO Health Clinical Trial Evaluating RAYALDEE in COVID-19 Patients » FDA Authorizes OPKO Health Clinical Trial Evaluating RAYALDEE in COVID-19 Patients MIAMI, June 01, 2020 (GLOBE NEWSWIRE...
Monday, June 1, 2020 (0 Comments - view/add) Aspire Health Science Announces US FDA Approval of IND Application Regarding Testing Proprietary ACT » Aspire Health Science Announces US FDA Approval of IND Application Regarding Testing Proprietary ACT-20 Cellular Therapy A...
Friday, May 29, 2020 (0 Comments - view/add) Hesperos Human-on-a-Chip® System Used to Model Preclinical Stages of Alzheimer’s Disease and Mild Co » Hesperos Human-on-a-Chip ® System Used to Model Preclinical Stages of Alzheimer’s Disease and Mild Cognitive Impairment...
Wednesday, May 27, 2020 (0 Comments - view/add) Lakewood-Amedex Receives Notice of Allowance for Two U.S. Patents Covering the Broad-Spectrum Antimi » Lakewood-Amedex Receives Notice of Allowance for Two U.S. Patents Covering the Broad-Spectrum Antimicrobial Nu-8 Bisphosph...
Thursday, May 21, 2020 (0 Comments - view/add) ADMA Biologics Commences Collection of COVID-19 Plasma from Recovered Patients » ADMA Biologics Commences Collection of COVID-19 Plasma from Recovered Patients...
Wednesday, May 20, 2020 (0 Comments - view/add) AGTC Announces Publication of Positive Preclinical Data that Provides Foundational Scientific Eviden » AGTC Announces Publication of Positive Preclinical Data that Provides Foundational Scientific Evidence for its Ongoing Cli...
Wednesday, May 20, 2020 (0 Comments - view/add) Cyclo Therapeutics Inc. Announces Positive Top Line Results from Phase I Trial and Interim Analysis » Cyclo Therapeutics Inc. Announces Positive Top Line Results from Phase I Trial and Interim Analysis of Phase I/II Trial us...
View "All News Items" »

Member Sign In

Forgot your password?

Don't have a profile?